These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31009392)

  • 21. Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type.
    Hong J; Park S; Baek HL; Jung JH; Kang IG; Sym SJ; Park J; Ahn JY; Cho EK; Kim ST; Shin DB; Lee JH
    Int J Clin Exp Pathol; 2012; 5(9):939-47. PubMed ID: 23119111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
    Kim SJ; Choi JY; Hyun SH; Ki CS; Oh D; Ahn YC; Ko YH; Choi S; Jung SH; Khong PL; Tang T; Yan X; Lim ST; Kwong YL; Kim WS;
    Lancet Haematol; 2015 Feb; 2(2):e66-74. PubMed ID: 26687611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Li P; Jiang L; Zhang X; Liu J; Wang H
    BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL).
    Rong Q; Gao Y; Cai Q; Wang X; Bai B; Ping L; He H; Rao H; Zhang Y; Li Z; Cai Q; Jiang W; Huang H
    Expert Rev Anticancer Ther; 2021 Jan; 21(1):121-127. PubMed ID: 33397158
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type.
    Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y
    Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate timing to perform an interim
    Wang R; Zhang Y; Fan Q; Jiang M; Zou L; Su M
    Ann Hematol; 2024 Mar; 103(3):885-892. PubMed ID: 38030892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
    Varelas AN; Ganti A; Eggerstedt M; Tajudeen BA
    Laryngoscope; 2019 Dec; 129(12):2675-2680. PubMed ID: 30801751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
    Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R
    Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series.
    Zhang YH; Li Z; Zhao S; Zhang WY; Liu QL; Liu WP; Gao LM
    Ann Hematol; 2023 Oct; 102(10):2803-2813. PubMed ID: 37434096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
    Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
    Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous extranodal natural killer (NK) / T - cell lymphoma: A comprehensive clinical features and outcomes analysis of 71 cases.
    Jiang L; Li P; Quan Q; Chen P; Qiu H; Zhang B
    Leuk Res; 2020 Jan; 88():106284. PubMed ID: 31841860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific Soft-Tissue Invasion and LMP1 Expression Are Potential Indicators of Extranodal NK/T Cell Lymphoma, Nasal Type.
    Jiang M; Lu H; Lu C; Geng X; Jia Y; Wang P; Qian W; Huang H; Shan X
    Med Sci Monit; 2018 Oct; 24():7603-7613. PubMed ID: 30356034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
    Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
    Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type.
    Yao N; Hou Q; Liang Y; Cao X; Sun B; Wei L; Sun R; Cao J
    Cancer Biomark; 2024; 39(4):265-275. PubMed ID: 38108343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
    Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
    Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of Pre-treatment Lymphocyte/Monocyte Ratio and Neutrophil/Lymphocyte Ratio on the Prognosis of Patients with Extranodal NK/T-Cell Lymphoma].
    Deng XY; Wang YY; Dang QQ; Liang TS; Zheng YJ; Yang DK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):707-713. PubMed ID: 37356930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type.
    Cho HJ; Jang MS; Hong SD; Kim SJ; Ahn YC; Oh D; Ko YH; Kim HY; Dhong HJ; Chung SK; Kim WS
    Int Forum Allergy Rhinol; 2015 Oct; 5(10):960-6. PubMed ID: 26039707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body mass index as a prognostic factor in patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Liu J; Deng YT; Zhang L; Li N; Jiang M; Zou LQ; Jiang Y
    Oncotarget; 2016 Nov; 7(47):78159-78167. PubMed ID: 27556299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.